Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more
Market Cap & Net Worth: Labiana Health S.A. (LAB)
Labiana Health S.A. (MC:LAB) has a market capitalization of $38.54 Million (€37.55 Million) as of March 24, 2026. Listed on the MC stock exchange, this Spain-based company holds position #27988 globally and #105 in its home market, demonstrating a 4.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labiana Health S.A.'s stock price €5.20 by its total outstanding shares 7221255 (7.22 Million).
Labiana Health S.A. Market Cap History: 2022 to 2026
Labiana Health S.A.'s market capitalization history from 2022 to 2026. Data shows growth from $24.91 Million to $38.54 Million (3.33% CAGR).
Labiana Health S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labiana Health S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
Labiana Health S.A.'s market cap is 0.43 times its annual revenue
1.06x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $24.91 Million | $57.85 Million | -$8.94 Million | 0.43x | N/A |
Competitor Companies of LAB by Market Capitalization
Companies near Labiana Health S.A. in the global market cap rankings as of March 24, 2026.
Key companies related to Labiana Health S.A. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #424 globally with a market cap of $50.88 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #428 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #449 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #711 globally with a market cap of $28.21 Billion USD ( CN¥206.95 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #424 | Zoetis Inc | NYSE:ZTS | $50.88 Billion | $115.67 |
| #428 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.07 |
| #449 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #711 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.21 Billion | CN¥55.14 |
Labiana Health S.A. Historical Marketcap From 2022 to 2026
Between 2022 and today, Labiana Health S.A.'s market cap moved from $24.91 Million to $ 38.54 Million, with a yearly change of 3.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €38.54 Million | +7.44% |
| 2025 | €35.88 Million | +63.51% |
| 2024 | €21.94 Million | +136.80% |
| 2023 | €9.27 Million | -62.80% |
| 2022 | €24.91 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 23rd, 2026 the market cap of Labiana Health S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.54 Million USD |
| MoneyControl | $38.54 Million USD |
| MarketWatch | $38.54 Million USD |
| marketcap.company | $38.54 Million USD |
| Reuters | $38.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.